Biologics and chronic obstructive pulmonary diseases

Biologics and chronic obstructive pulmonary diseases

The presence of airway inflammation in patients with chronic obstructive pulmonary disease (COPD) provides a rationale for biological agents targeting specific inflammatory pathways. This approach has been strikingly effective in patients with other chronic inflammatory diseases, such as rheumatoid...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας:	Pavord, I
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Elsevier 2018

Παρόμοια τεκμήρια

GLUCOLD, eosinophils and chronic obstructive pulmonary disease
ανά: Pavord, I
Έκδοση: (2018)

Chronic obstructive pulmonary disease in non-smokers.
ανά: Pavord, I, κ.ά.
Έκδοση: (2009)

Asthma-like features and chronic obstructive pulmonary disease.
ανά: Hynes, G, κ.ά.
Έκδοση: (2016)

Mepolizumab for eosinophilic chronic obstructive pulmonary disease
ανά: Pavord, I, κ.ά.
Έκδοση: (2017)

Chronic obstructive pulmonary disease – management of chronic disease
ανά: Ramakrishnan, S, κ.ά.
Έκδοση: (2020)

Chronic obstructive pulmonary disease: Management of chronic disease
ανά: Russell, R, κ.ά.
Έκδοση: (2012)

Chronic obstructive pulmonary disease: management of chronic disease
ανά: Bafadhel, M, κ.ά.
Έκδοση: (2016)

Chronic obstructive pulmonary disease: Management of chronic disease
ανά: Hambleton, K, κ.ά.
Έκδοση: (2016)

Allergic rhinitis, asthma, airway biology, and chronic obstructive pulmonary disease in AJRCCM in 2004.
ανά: Fabbri, L, κ.ά.
Έκδοση: (2005)

Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.
ανά: Bafadhel, M, κ.ά.
Έκδοση: (2011)

Peptic ulceration, Helicobacter pylori seropositivity and chronic obstructive pulmonary disease.
ανά: Siva, R, κ.ά.
Έκδοση: (2013)

Nocturnal hypoxaemia in chronic obstructive pulmonary disease.
ανά: Stradling, JR, κ.ά.
Έκδοση: (1983)

Biological clustering supports both "Dutch" and "British" hypotheses of asthma and chronic obstructive pulmonary disease.
ανά: Ghebre, M, κ.ά.
Έκδοση: (2015)

Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease.
ανά: Barker, B, κ.ά.
Έκδοση: (2014)

Exacerbations of chronic obstructive pulmonary disease: Time to rename
ανά: Bafadhel, M, κ.ά.
Έκδοση: (2019)

Invasive to noninvasive ventilation in chronic obstructive pulmonary disease
ανά: Sharma, R, κ.ά.
Έκδοση: (2003)

Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design.
ανά: Gamble, E, κ.ά.
Έκδοση: (2006)

The importance of movement for people living with chronic obstructive pulmonary disease.
ανά: Williams, V, κ.ά.
Έκδοση: (2011)

Current controversies in chronic obstructive pulmonary disease. A report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee
ανά: Criner, GJ, κ.ά.
Έκδοση: (2019)

Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability.
ανά: Brightling, C, κ.ά.
Έκδοση: (2001)

Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
ανά: Brightling, C, κ.ά.
Έκδοση: (2005)

Induced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease.
ανά: Saha, S, κ.ά.
Έκδοση: (2008)

Towards eradication of chronic obstructive pulmonary disease: a Lancet Commission.
ανά: Dransfield, M, κ.ά.
Έκδοση: (2019)

Anxiety and panic in chronic obstructive pulmonary disease: The role of catastrophic thoughts
ανά: Gurney-Smith, B, κ.ά.
Έκδοση: (2002)

Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease.
ανά: Bafadhel, M, κ.ά.
Έκδοση: (2012)

Impaired mitochondrial microbicidal responses in chronic obstructive pulmonary disease macrophages
ανά: Bewley, M, κ.ά.
Έκδοση: (2017)

Indoor air quality in homes of patients with chronic obstructive pulmonary disease.
ανά: Osman, L, κ.ά.
Έκδοση: (2007)

Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk
ανά: Rao, S, κ.ά.
Έκδοση: (2023)

Use of the Oxford Participation and Activities Questionnaire in chronic obstructive pulmonary disease
ανά: Morley, D, κ.ά.
Έκδοση: (2019)

HOSPITAL AT HOME IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: IS IT A VIABLE OPTION?
ανά: Shepperd, S, κ.ά.
Έκδοση: (2012)

Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease.
ανά: Gamble, E, κ.ά.
Έκδοση: (2003)

Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study.
ανά: Birring, S, κ.ά.
Έκδοση: (2002)

Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis
ανά: Pavord, I, κ.ά.
Έκδοση: (2016)

Chronic obstructive pulmonary disease, risk factors, and outcome trials: comparisons with cardiovascular disease.
ανά: Ramsey, S, κ.ά.
Έκδοση: (2006)

Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial.
ανά: Brightling, C, κ.ά.
Έκδοση: (2000)

Intravenous iron and chronic obstructive pulmonary disease: a randomised controlled trial
ανά: Santer, P, κ.ά.
Έκδοση: (2020)

Predictors of influenza PCR positivity in acute exacerbations of chronic obstructive pulmonary disease
ανά: Chen, Calvin You Jia, κ.ά.
Έκδοση: (2022)

Applying next-generation sequencing and multi-omics in chronic obstructive pulmonary disease
ανά: Tiew, Pei Yee, κ.ά.
Έκδοση: (2023)

Some chronic obstructive pulmonary disease will originate in neonatal intensive care units.
ανά: Bentham, JR, κ.ά.
Έκδοση: (2005)

Pre‐operative optimisation for chronic obstructive pulmonary disease: a narrative review
ανά: Lee, A, κ.ά.
Έκδοση: (2020)